<DOC>
	<DOCNO>NCT02087397</DOCNO>
	<brief_summary>This open-label , non-randomized , multi-center , patient sponsor study Adipose-Derived Stromal Vascular Fraction cell ( AD-SVF ) implantation deliver corpus cavernous patient Erectile Dysfunction . The intent clinical study answer question : 1 ) Is propose treatment safe 2 ) Is treatment effective improve disease pathology patient diagnose Erectile Dysfunction .</brief_summary>
	<brief_title>Autologous Adipose-Derived Stromal Cells Delivered Into Corpus Cavernous Patients With Erectile Dysfunction</brief_title>
	<detailed_description>AD-SVF collect patient 's adipose-derived tissue ( body fat ) . Using local anesthesia , Liposuction perform collect adipose tissue specimen . The adipose tissue transfer laboratory separation adipose tissue derive stem cell . In addition , peripheral blood collect isolation platelet rich plasma , combine ASC 's direct injection Corpus Cavernosum ( Penis ) .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Inclusion Criteria Males Age 18 80 year . Penile arterial insufficiency venous leakage ( doppler ) time inclusion : PSV &lt; 25 cm/sec , PSV &gt; 25 cm/sec , EDV &gt; 5cm/sec , RI &lt; 0,75 . Up date age gender appropriate cancer screen per American Cancer Society Exclusion Criteria Severe comorbidities like cardiac insufficiency , congestive cardiac failure ( NYHA ≥ III ) , malignancy , infection , sepsis bed sore . Life expectancy &lt; 6 month due concomitant illness . Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . Patients know tested positive HIV , HTLV , HBV , HCV , CMV ( IgM &gt; IgG ) and/or syphilis evaluate expert patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , \ interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) ≤90 mmHg great 200mmHg Resting heart rate &gt; 100 bpm ; Active clinical infection within one week enrollment . Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Unwilling and/or able give write informed consent .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Stem Cell</keyword>
	<keyword>Erectile Dysfunction</keyword>
</DOC>